Microbot Medical Inc (MBOT) has released an update.
On January 29, 2024, the Company applied for an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration to begin a pivotal clinical trial in humans.
For further insights into MBOT stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
